Showing results (2051-2060 of 9,628) with videos related to
Sort By:
Pageof 963
Leukemia|February 23, 2016
TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapyE Nievergall, J Reynolds, C H Kok, et al.Leukemia|February 23, 2016
High-affinity FRβ-specific CAR T cells eradicate AML and normal myeloid lineage without HSC toxicityR C Lynn, Y Feng, K Schutsky, et al.Leukemia|March 19, 2016
High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-XL in chronic myeloid leukemiaC M Lucas, M Milani, M Butterworth, et al.Leukemia|March 12, 2016
MIM regulates the trafficking of bone marrow cells via modulating surface expression of CXCR4T Zhan, C Cao, L Li, et al.Leukemia|August 1, 2015
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter surveyR Zeiser, A Burchert, C Lengerke, et al.Leukemia|December 24, 2014
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocationF Abate, M Todaro, J-A van der Krogt, et al.Leukemia|August 19, 2015
Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trialJ M Middeke, R Herbst, S Parmentier, et al.Leukemia|May 1, 1989
Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factorC Carlo-Stella, M Cazzola, G Bergamaschi, et al.Leukemia|October 22, 2015
Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemiaS Wakita, H Yamaguchi, T Ueki, et al.Leukemia|October 23, 2015
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active diseaseE Zamagni, C Nanni, F Gay, et al.Pageof 963